Seymour June Ann

Cartesian Therapeutics, Inc. · Chief Accounting Officer

Seymour June Ann is listed in filings as Chief Accounting Officer at Cartesian Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 6, 2026, including 3 public disclosures. Recent filings connect the profile to Cartesian Therapeutics, Inc. (RNAC). The current snapshot covers public activity from Oct 28, 2025 to Jan 6, 2026. Reported amounts are shown as $128.4K to $442.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.
Seymour June Ann History Trades | TradingNote